David W. Vaughn And NotVictoria (État)
List of bibliographic references
Number of relevant bibliographic references: 6.Ident. | Authors (with country if any) | Title |
---|---|---|
000B55 | Olivier Godeaux [Belgique] ; Patricia Izurieta [Belgique] ; Miguel Madariaga [États-Unis] ; Mamadou Dramé [États-Unis] ; Ping Li [États-Unis] ; David W. Vaughn [Belgique] | Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years. |
000B56 | Timo Vesikari [États-Unis] ; Jan Hendrik Richardus ; Johan Berglund ; Tiina Korhonen ; Carl-Erik Flodmark ; Ann Lindstrand ; Sven Arne Silfverdal ; Vinod Bambure ; Adrian Caplanusi ; Ilse Dieussaert ; Sumita Roy-Ghanta ; David W. Vaughn | Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials. |
001A32 | Joanne M. Langley [Canada] ; Dennis Reich ; Naresh Aggarwal ; David Connor ; Marc H. Lebel ; Anil Gupta ; Hartley Garfield ; Ping Li ; Anu Madan ; David W. Vaughn | Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity. |
001F50 | Joanne M. Langley [Canada] ; Dennis Reich [Canada] ; Naresh Aggarwal [Canada] ; David Connor [Canada] ; Marc H. Lebel [Canada] ; Anil Gupta [Canada] ; Hartley Garfield [Canada] ; PING LI [États-Unis] ; Anu Madan [États-Unis] ; David W. Vaughn [États-Unis] | Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age: Safety and Immunogenicity |
002487 | George Risi [États-Unis] ; Louise Frenette ; Joanne M. Langley ; Ping Li ; Dennis Riff ; Eric Sheldon ; David W. Vaughn ; Louis Fries | Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months. |
002C83 | George Risi [États-Unis] ; Louise Frenette [Canada] ; Joanne M. Langley [Canada] ; PING LI [États-Unis] ; Dennis Riff [États-Unis] ; Eric Sheldon [États-Unis] ; David W. Vaughn [États-Unis] ; Louis Fries [États-Unis] | Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months |
This area was generated with Dilib version V0.6.34. |